Opko Health to sell more assets to LabCorp

Labcorp to buy Opko unit’s cancer test assets for up to $225M
Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth testing areas.
Opko Health to sell more assets to Labcorp for $225 million
The sale comes after the Miami company agreed to pay $704,349 to settle allegations that it billed the federal government for unnecessary blood tests.
Labcorp to acquire certain assets of Opko Health’s BioReference Health
Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million
Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for BioReference's laboratory testing businesses, which is focused on oncology and oncology-related clinical testing services across the U.S.
Labcorp to acquire select oncology testing assets for up to $225M
The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
Labcorp pays $225 million for BioReference's oncology testing lines in latest acquisition
Labcorp continues string of acquisitions with a deal adding BioReference oncology services in $225 million deal. Burlington-based Labcorp is investing almost a quarter of a billion dollars to add oncology testing services in its most recent acquisition.
OPKO stock climbs 4% on better-than-expected Q4 report
Shares of OPKO Health (NASDAQ:OPK) climbed 4% in after-hours trading Thursday following a better-than-expected Q4 earnings report. OPKO (NASDAQ:OPK) reported a net profit of $0.01 per share on revenue ...
OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands
The strength in OPKO Health's transfer of intellectual property and other revenues boosts its overall fourth-quarter 2024 ...
Opko Health (OPK) Q4 2024 Earnings Call Transcript
Operator Good day, and welcome to the OPKO Health fourth quarter 2024 financial results conference call. All participants will be in a listen-only mode. [Operator instructions] After today's ...
Labcorp, Opko Health acquire certain assets of BioReference Health
Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...